Frank Karbe Cidara Therapeutics, Inc. (CDTX) insider trading activity

CDTX Quotes by TradingView

Frank Karbe is Chief Financial Officer of Cidara Therapeutics, Inc.. Currently has a direct ownership of 50,562 shares of CDTX, which is worth approximately $11 Million. The most recent transaction as insider was on Dec 10, 2025, when has been sold 7,290 shares (Common Stock) at a price of $219.6 per share, resulting in proceeds of $1,600,884. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 50.6K
12.07% 3M change
n/a 12M change
Total Value Held $11 Million

FRANK KARBE Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 10 2025
SELL
Payment of exercise price or tax liability
$1,600,884 $219.6 p/Share
7,290 Reduced 12.6%
50,562 Common Stock
Feb 24 2025
BUY
Grant, award, or other acquisition
-
57,500 Added 50.0%
57,500 Common Stock

Also insider at

MYOV
Myovant Sciences Ltd. Healthcare
Principal Fin'l & Accounting
PHAT
Phathom Pharmaceuticals, Inc. Healthcare
BTTX
Better Therapeutics, Inc. Healthcare
Chief Executive Officer
FK

Frank Karbe

Chief Financial Officer
San Francisco, CA

Track Institutional and Insider Activities on CDTX

Follow Cidara Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CDTX shares.

Notify only if

Insider Trading

Get notified when an Cidara Therapeutics, Inc. insider buys or sells CDTX shares.

Notify only if

News

Receive news related to Cidara Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on CDTX